For the Quarter Ending June 2025
North America
• The Dipotassium EDTA Spot Price in North America saw stable-to-soft movement in Q2 2025, mirroring import-linked sentiment from Asia and restrained offtake across pharmaceutical and food sectors.
• The Price Index remained largely neutral, with an estimated fluctuation of -1% to +0.5% through the quarter, as import prices softened and domestic demand stayed subdued.
• The Dipotassium EDTA Production Cost Trend was influenced by declining global input prices, particularly for formaldehyde and EDTA precursors, leading to reduced import cost pressures for U.S. formulators.
• The Dipotassium EDTA Demand Outlook showed weakness in Q2, as several pharmaceutical companies maintained high opening inventories, avoiding restocking, while the food preservation segment remained inactive.
• Buyers in personal care and hygiene product sectors continued routine procurement, but volumes were insufficient to shift overall market pricing or consumption significantly.
• Distribution channels across the U.S. functioned efficiently, and no freight challenges were recorded during the quarter, enabling stable availability and conservative procurement practices.
• The Dipotassium EDTA Price Forecast for North America points toward cautious sentiment, with any potential price rebounds in Q3 hinging on export-import parity adjustments and seasonal cleaning agent demand.
• Local formulators in contract manufacturing opted to delay bulk purchases, citing soft price trends and uncertain Q3 demand scenarios in OTC preparations and topical formulations.
• In July 2025, prices decreased slightly by an estimated 0.3–0.5% due to continued weak buying interest and pass-through effect of lower Asian export offers.
Asia Pacific (APAC)
• The Dipotassium EDTA Spot Price in Indian market remained stable in Q2 and closed at USD 2872/MT in June. It followed a marginal increase of 0.45% that was backed by softened input costs and steady downstream demand.
• The Price Index showed a net Q2 growth of approx. 0.8%, with only modest price variation across April (+1.17%), May (-5.77%) and June (+0.45%) due to alternating cost and demand influences.
• The Dipotassium EDTA Production Cost Trend saw relief from falling feedstock costs—particularly formaldehyde and EDA—helping suppliers maintain margin stability and avoid sharp price hikes.
• The Dipotassium EDTA Demand Outlook in APAC remained consistent in Q2 with balanced consumption from pharmaceutical formulations, nutraceuticals and personal care sectors throughout the summer.
• Buyers across India adopted need-based procurement, aided by well-maintained inventories and absence of supply-side bottlenecks, which stabilized price sentiment despite seasonal activity.
• In April, export and domestic demand improved moderately, lifting prices slightly, but was followed by a May dip due to weak pharmaceutical uptake. A modest June rebound kept quarterly movement subdued.
• The Dipotassium EDTA Price Forecast for APAC suggests a continued stable-to-soft trend into early Q3 as input prices stabilize and consumer industries maintain cautious procurement cycles.
• There were no logistics disruptions during India’s monsoon, enabling smooth distribution, which further muted any aggressive price fluctuations in the region.
• In July 2025, prices are expected to remain stable or soften slightly due to accumulated inventories and restrained buying in the pharmaceutical segment, despite ongoing cosmetic sector support.
Europe
• The Dipotassium EDTA Spot Price in Europe remained stable with slight weakness through Q2 2025, following similar dynamics as APAC and North America. Prices ranged within a narrow band of USD 2900–2950/MT.
• The Price Index showed a quarter-on-quarter drop of approximately 1.5%, led by weak demand from pharmaceuticals and a shift toward lower-cost chelating alternatives in formulation planning.
• The Dipotassium EDTA Production Cost Trend benefited from cheaper Asian imports and declining raw material prices, giving European blenders price negotiation leverage in bulk purchasing rounds.
• The Dipotassium EDTA Demand Outlook was affected by inventory saturation in Q1, limiting Q2 uptake, though cosmetics and cleaning agents sectors continued with standard consumption cycles.
• Formulators in Germany, France, and Italy avoided long-term procurement, citing uncertainty around Q3 consumption and broader EU pharmaceutical output volatility.
• The market witnessed active price negotiations in May–June, but no significant supply shortage or production constraints occurred to disrupt availability.
• With freight rates from Asia softening, importers leveraged lower-cost landed cargoes to support domestic formulation operations, restraining any price rally.
• The Dipotassium EDTA Price Forecast for Europe remains neutral for early Q3, pending stronger demand indicators or supply chain tightening, which is currently absent.
• In July 2025, Dipotassium EDTA prices in Europe declined modestly, driven by reduced pharmaceutical demand, availability of low-cost imports, and subdued regional production activity.
For the Quarter Ending March 2025
North America
In North America, Dipotassium EDTA prices showed a stable to slightly firm trend through the first quarter of 2025. While exact price change data was not widely reported, market behaviour suggests a slight upward push in line with trends observed in global markets.
Procurement activity in pharmaceuticals and food sectors was paced and steady. Buyers avoided excessive stocking but maintained healthy inventory levels. There was no major disruption in supply. Most shipments reached on time, and there were no sharp changes in freight charges. The transition from winter to spring did not bring much fluctuation in consumption patterns. However, suppliers saw steady inquiries from food and beverage manufacturers. This helped keep the sentiment slightly positive.
Some mild effects of trade regulations and tariff adjustments were also noted. These were not disruptive but did influence the pricing environment slightly. Sellers did not push prices aggressively, and buyers were ready to accept marginal increases for confirmed deliveries. Overall, the market moved in a balanced manner. Price firmness appeared more due to disciplined procurement and moderate but consistent demand.
Asia Pacific
In the Asia Pacific region, Dipotassium EDTA prices increased by around 2.73 percent during the first quarter of 2025. The rise came as suppliers handled demand steadily across pharmaceutical, food and personal care sectors. There was no sharp jump in consumption, but procurement remained regular. Buyers preferred timely restocking to avoid future delays. This kept inventories at a safe level. Supply chains operated well in entire region despite some minor delays around the Lunar New Year.
The seasonal transition in APAC region and holidays in China led to shorter working periods which mildly affected trading pace. However, overall availability was not disrupted. Demand across the region stayed firm especially in nutraceutical and skin care applications. Some buyers increased booking volumes in the later part of the quarter. This added to the upward price push. The market tone stayed positive but stable. There was no sign of panic buying or overstocking. Logistics remained smooth, and prices moved upward mainly due to consistent demand and stable procurement.
Europe
In Europe, the Dipotassium EDTA market remained relatively stable through the first quarter of 2025. There were no significant shifts in pricing, but a soft upward movement was noted in key markets. This reflected the broader global trend of consistent demand and European market mirrored the same.
Buyers in Europe followed cautious procurement strategies. Orders were placed in smaller batches based on usage and forecasted needs. Inventory remained well managed. Suppliers did not report any major production changes. Supply was available across key regions without notable delay. Demand from pharmaceutical and personal care sectors supported a mild uptick in sentiment. Skin care and hair care applications saw steady consumption. Buyers preferred confirmed deliveries from trusted sources and avoided speculative buying.
There was no panic or sudden rise in consumption. Freight and logistics across the region worked without major interruption. Even though local pricing data was not widely disclosed, market behaviour indicated a soft and manageable price environment. Slight firmness in pricing seemed driven more by demand stability and regular restocking than by any tightness in availability.
For the Quarter Ending December 2024
North America
The North American Dipotassium EDTA market navigated a complex economic landscape in Q4 2024, characterized by nuanced supply chain dynamics and resilient industrial demand. Market performance reflected moderate supply constraints stemming from limited domestic production capacity and intermittent import challenges.
Manufacturing sector performance demonstrated remarkable adaptability, signaling sustained growth potential. Strategic priorities centered on supply chain optimization, technological process automation, and sophisticated cost management approaches. Critical downstream sectors, including food processing, pharmaceutical manufacturing, and personal care industries, maintained robust consumption patterns, providing essential market stability.
The market's inherent resilience emerged through strategic inventory adjustments and adaptive pricing mechanisms. While experiencing temporary supply-demand imbalances, the North American Dipotassium EDTA ecosystem showcased its capacity to recalibrate and respond to evolving economic conditions. Technological innovation and consistent industrial demand positioned the market for potential future growth, underlining the sector's structural strength and strategic importance in advanced manufacturing value chains.
Asia
The Indian Dipotassium EDTA market demonstrated Stable bearish momentum in Q4 2024, driven by significant demand-supply imbalances and rising domestic consumption. Supply constraints stemmed from reduced imports, limited production capacity, and labor shortages during the festive season. Meanwhile, downstream sectors saw heightened demand due to pre-winter procurement activities and strong industrial consumption. Elevated spot market premiums reflected structural market strength, with price gains driven by demand fundamentals rather than speculative activity.
India’s manufacturing sector also showed resilience, with the PMI peaking at 57.5 in October before moderating to 56.5 in November, signaling sustained growth despite rising input costs and competitive pressures. The sector focused on automation, supply chain optimization, and product innovation to mitigate cost inflation, maintain productivity, and ensure long-term growth.
As the quarter progressed, deliberate inventory adjustments and currency depreciation created a temporary pricing standoff in the Dipotassium EDTA market. However, with stable downstream demand in food, cosmetics, and pharmaceuticals, the market is poised to stabilize, showcasing its resilience amid evolving dynamics. As Q4 2024 concluded, the latest quarter-ending price for Dipotassium EDTA 98% Ex-Vadodara in India settled at USD 2867.09/MT showcasing average quarterly decline of 0.67%, further underscoring the prevailing negative pricing environment in the region.
Europe
The European Dipotassium EDTA market in Q4 2024 witnessed fluctuating prices, shaped by its dependence on imports from India and ripple effects from declining APAC prices. Despite delayed impacts due to contractual commitments and logistical timelines, the region faced challenges in maintaining a balance between competitive import pricing and sufficient inventory levels.
Cautious procurement strategies emerged across downstream industries, amplifying market uncertainty and contributing to a restrained buying sentiment. European market prices trended downward gradually, mirroring but not fully matching the sharper declines in India. Pricing dynamics were closely tied to Indian export rates, with freight costs and Euro-USD currency fluctuations adding complexity to the landscape. This intricate interplay of global influences highlighted the region’s vulnerability to external market pressures.
As the quarter closed, the European market showcased resilience while adapting to evolving conditions. With these trends expected to persist, stakeholders remain focused on navigating challenges and seizing opportunities in the upcoming quarters.
For the Quarter Ending September 2024
North America
During Q3 2024, the US market for Dipotassium EDTA faced challenges akin to those in Europe, primarily due to its significant reliance on imports from India. The dynamics of this market were shaped by a confluence of international pricing trends and evolving domestic demand patterns. US buyers adopted a cautious procurement strategy, vigilantly monitoring the declining prices in the Indian market while strategically managing their inventory levels to avoid overstocking in a volatile environment.
The prevailing sentiment among domestic end-users remained cautious, prompting many to adopt a wait-and-watch approach in light of global price uncertainties. This approach reflects a broader market hesitancy, as stakeholders anticipate potential shifts in pricing trends. As an import-dependent region, US market prices exhibited a pronounced correlation with Indian export prices, though this relationship was further complicated by factors such as extended transportation times and elevated logistics costs associated with trans-Pacific shipments.
Throughout the quarter, prices exhibited a consistent downward trajectory, mirroring global trends. However, the US market faced additional challenges due to transportation premiums and regional distribution costs, leading to a nuanced pricing landscape that diverged from Indian export prices.
Asia
Throughout Q3 2024, the APAC region faced a challenging landscape for Dipotassium EDTA pricing, marked by a persistent decline in prices. This downward trend can be attributed to several interrelated factors, including weak demand across multiple industries, an oversupplied market, and fluctuating raw material costs. The combination of these elements fostered a negative sentiment among market participants, significantly impacting pricing dynamics. Additionally, disruptions such as plant shutdowns exacerbated the situation, further contributing to the downward pressure on prices.
The most pronounced effects were observed in India, where market volatility led to the most significant price changes. Throughout the quarter, prices exhibited a seasonal pattern, demonstrating a steady decrease. The correlation between price fluctuations and market conditions was clear, with a direct relationship observed between demand levels, supply dynamics, and pricing trends. Notably, the percentage change from the previous quarter remained stagnant at 0%, indicating a prolonged downward trajectory. A comparative analysis of prices between the first and second halves of the quarter revealed a decline of 1%.
As Q3 2024 concluded, the latest quarter-ending price for Dipotassium EDTA 98% Ex-Vadodara in India settled at USD 245,000/MT, further underscoring the prevailing negative pricing environment in the region. This development highlights the need for market participants to navigate carefully in light of ongoing challenges.
Europe
Throughout Q3 2024, the European market for Dipotassium EDTA experienced notable price fluctuations, significantly influenced by its heavy reliance on imports from India. The region felt a cascading effect from declining prices in the APAC market, although this impact was somewhat delayed due to existing contractual obligations and transportation timelines. As European market participants navigated these complexities, they encountered challenges in inventory management, striving to balance the need for competitive import prices with the necessity of maintaining adequate stock levels.
Downstream industries exhibited cautious buying patterns, reflecting a broader sense of market uncertainty. This hesitation contributed to a subdued market sentiment, further complicating the pricing landscape. As a primary importing region, Europe’s pricing dynamics were intricately linked to Indian export prices, logistics costs, and fluctuations in regional demand
Throughout the quarter, European prices displayed a gradual downward trend, albeit less pronounced than in the Indian market. The strong correlation between European market prices and Indian export rates remained evident, with additional considerations such as freight costs and the Euro-USD exchange rate significantly influencing overall market dynamics. These interconnected factors will likely continue to shape the Dipotassium EDTA landscape in the upcoming quarters.
Frequently Asked Questions (FAQs)
1. What are the primary applications of Dipotassium EDTA in various industries?
Dipotassium EDTA is widely used as a chelating agent in pharmaceutical formulations, personal care products, and food preservation. It helps stabilize formulations by binding metal ions, enhancing shelf life and product performance.
2. What factors influenced Dipotassium EDTA prices in Q2 2025?
Prices were primarily influenced by fluctuations in demand from pharmaceutical and cosmetic sectors, changes in upstream raw material costs (such as formaldehyde and ethylenediamine), and the availability of stable inventory levels across key markets.
3. Why did Dipotassium EDTA prices remain relatively stable in Asia during Q2?
The price stability in Asia was due to consistent demand from end-use sectors, falling raw material costs, and the absence of supply disruptions. Most buyers followed need-based procurement, avoiding aggressive restocking.
4. Are there any seasonal trends in Dipotassium EDTA consumption?
Yes, demand often fluctuates with seasonal changes in personal care and pharmaceutical production. For instance, increased use of topical and oral hygiene products during warmer months can lead to a moderate rise in consumption.
5. What is the price outlook for Dipotassium EDTA in Q3 2025?
The price trend is expected to remain stable to slightly soft across major regions, unless there is a significant pickup in procurement from pharmaceutical manufacturers or changes in feedstock dynamics.
